Related references
Note: Only part of the references are listed.Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma
B. Esmaeli et al.
ANNALS OF ONCOLOGY (2009)
Estimation of yttrium-90 Zevalin tumor-absorbed dose in ocular adnexal lymphoma using quantitative indium-111 Zevalin radionuclide imaging
William D. Erwin et al.
NUCLEAR MEDICINE COMMUNICATIONS (2009)
Ocular adnexal lymphoid tumors: Progress in need of clarification
Frederick A. Jakobiec
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma
TE Witzig et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
